Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
44 hedge funds and large institutions have $99.1M invested in Global Cord Blood Corporation in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
10% more funds holding
Funds holding: 40 → 44 (+4)
20% less capital invested
Capital invested by funds: $124M → $99.1M (-$24.9M)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$2.73M |
| 2 |
Renaissance Technologies
New York
|
+$992K |
| 3 |
Morgan Stanley
New York
|
+$950K |
| 4 |
Millennium Management
New York
|
+$711K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$446K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.93M |
| 2 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
-$2.66M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.32M |
| 4 |
SG Americas Securities
New York
|
-$776K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$524K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| – | -$2.62K | -500 | -96% |
|
CO Hedge Fund Activity: Q3 2019 in Review
44 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2019, worth a combined $99.1M — down 20% from $124M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CO positions and 7 closed out — a net gain of 4 holders — while 8 added to existing stakes and 13 trimmed.
The largest buyer was Oasis Management Company, adding an estimated $2.73M. The largest seller was Vanguard Group, exiting entirely with an estimated $6.93M sold.
- 44 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2019, up from 40 in Q2 2019.
- Funds reported $99.1M of Global Cord Blood Corporation stock for Q3 2019, down 20% quarter-over-quarter.
- 11 funds opened new Global Cord Blood Corporation positions in Q3 2019 and 7 closed out, a net change of +4 holders.
- The largest Global Cord Blood Corporation buyer in Q3 2019 was Oasis Management Company, an estimated $2.73M added.
- The largest Global Cord Blood Corporation seller in Q3 2019 was Vanguard Group, an estimated $6.93M sold.
Based on aggregated 13F filings for Q3 2019.